-
- 抗原 See all APOA5 抗体
- APOA5 (Apolipoprotein A-V (APOA5))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This APOA5 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC)
- 纯化方法
- purified
- 免疫原
- Purified recombinant fragment of human Apoa5 expressed in E. coli.
- 克隆位点
- 2G1H11
- 亚型
- IgG1
- Top Product
- Discover our top product APOA5 Primary Antibody
-
-
- 应用备注
- ELISA: 1:10000, WB: 1:500 - 1:2000, ICC: 1:200 - 1:1000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Purified antibody in PBS containing 0.03 % sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C/-20 °C
- 储存方法
- 4°C, -20°C for long term storage
-
-
The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element." in: The Journal of biological chemistry, Vol. 278, Issue 28, pp. 25468-80, (2003) (PubMed).
: "An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing." in: Science (New York, N.Y.), Vol. 294, Issue 5540, pp. 169-73, (2001) (PubMed).
: "
-
The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element." in: The Journal of biological chemistry, Vol. 278, Issue 28, pp. 25468-80, (2003) (PubMed).
-
- 抗原
- APOA5 (Apolipoprotein A-V (APOA5))
- 别名
- APOA5 (APOA5 产品)
- 别名
- APOAV antibody, RAP3 antibody, 1300007O05Rik antibody, Apoav antibody, apo-AV antibody, apoA-V antibody, APOA5 antibody, MGC140487 antibody, rap3 antibody, apoav antibody, apoa-v antibody, apolipoprotein A5 antibody, apolipoprotein A-V antibody, apolipoprotein A5 L homeolog antibody, APOA5 antibody, Apoa5 antibody, apoa5.L antibody, apoa5 antibody
- 背景
-
Description: Apolipoprotein A5 (ApoA5) is fast gaining attention as a key regulator of serum triglyceride concentrations. An ApoA5 mouse knock-out model produced an approximately four fold increase in serum triglycerides, whereas a knock-in model with human ApoA5 produced 50-70 % lower concentrations of mouse serum triglycerides. In addition, peroxisome proliferator-activated receptor- agonists, which are used clinically to lower serum triglyceride concentrations, cause increased ApoA5 mRNA expression. Despite these compelling molecular biology data, relatively little is known about ApoA5 protein in human serum. This antibody pair detected recombinant apoa5 protein in sandwich ELISA format and could be potential reagents for the development of clinical diagnostic kits.
Aliases: RAP3, APOAV, APOA-V, MGC126836, MGC126838
- 基因ID
- 116519
- HGNC
- 116519
- 途径
- Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
-